Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 20, 2018
Nov.20 -- John Thero, chief executive officer at Amarin, talks about early results for their heart drug Vascepa. David Kotok, chairman and chief investment officer at Cumberland Advisors, joins the conversation on "Bloomberg Daybreak: Americas."